Guardant Health
GH
#1171
Rank
C$27.71 B
Marketcap
C$204.88
Share price
-0.52%
Change (1 day)
51.14%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

ESG Reports

Thumbnail Guardant Health
 ESG Report 2024

ESG Report 2024

Language: English

View ESG Report
Thumbnail Guardant Health
 ESG Report 2023

ESG Report 2023

Language: English

View ESG Report